Results 71 to 80 of about 6,621 (153)
Clinical and Hematological Outcomes of Aminocaproic Acid Use During Pediatric Cardiac ECMO. [PDF]
Coleman M +3 more
europepmc +1 more source
Local administration of epsilon-aminocaproic acid reduces post-operative blood loss from surgery for closed, Sanders III-IV calcaneal fractures. [PDF]
Zhong L, Xu Y, Wang Y, Liu Y, Huang Q.
europepmc +1 more source
Introduction: To reduce intraoperative blood loss and the use of transfusion requirements, antifibrinolytic agents that repermeabilize a bleeding vessel are used.
Zaily Fuentes Díaz +2 more
doaj +2 more sources
Introduction/Justification: Cancer remains one of the leading causes of mortality worldwide. Consequently, efforts to overcome the limitations of conventional therapies have increasingly focused on molecularly targeted treatments, with particular ...
Leonardo Yumoto Carvalheira +5 more
doaj +1 more source
Tranexamic Acid versus Epsilon-Aminocaproic Acid in Total Knee Arthroplasty: A Meta-Analysis.
Li Z, Sun X, Li W, Zhang M.
europepmc +1 more source
Magnetically controlled protein nanocontainers as a drug depot for the hemostatic agent
Artur Prilepskii, Alexandra Schekina, Vladimir VinogradovITMO University, International Institute “Solution Chemistry of Advanced Materials and Technologies” (SCAMT), Saint Petersburg 191002, Russian FederationPurpose: Currently, there is a ...
Prilepskii A, Schekina A, Vinogradov V
doaj
Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series. [PDF]
Simon RP +4 more
europepmc +1 more source
Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?
Deepak K Tempe, Suruchi Hasija
doaj +1 more source

